Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Paricalcitol is a synthetic 1,25-dihydroxy vitamin D2 analog. As vitamin D deficiency, associated with chronic kidney disease, leads to an increase in parathyroid hormone (secondary hyperparathyroidism), paricalcitol is used in renal patients to block parathyroid hormone overproduction.1,2,3 Vitamin D deficiency is also a risk factor in cancer, cardiovascular disease, hypertension, and diabetes, and paricalcitol may have applications in those contexts as well.4
WARNING This product is not for human or veterinary use.
1. Calcemic activity of 19-
2. Beneficial effects of selective vitamin D receptor activation by paricalcitol in chronic kidney disease. Curr. Drug Targets 15(7), 703-709 (2014).
3. Vitamin D in patients with renal failure: A summary of observational mortality studies and steps moving forward. J. Steroid Biochem. Mol. Biol. 103(3-5), 487-490 (2007).
4. The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection. Clin. Interv. Aging 8, 149-156 (2013).